Blackman Samuel's Insider Trades & SAST Disclosures
Blackman Samuel's most recent trade in Day One Biopharmaceuticals Inc was a trade of 30,000 Common Stock done at an average price of $13.3 . Disclosure was reported to the exchange on Dec. 10, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Blackman Samuel.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Day One Biopharmaceuticals... | Blackman Samuel | HEAD OF R&D | 10 Dec 2024 | 30,000 | 1,034,015 | - | 13.3 | 399,339 | Common Stock | |
| Day One Biopharmaceuticals... | Samuel Blackman | HEAD OF R&D | 15 Nov 2024 | 6,062 | 72,752 | - | - | Restricted Stock Unit (RSU) | ||
| Day One Biopharmaceuticals... | Samuel Blackman | HEAD OF R&D | 15 Nov 2024 | 6,062 | 1,066,221 | - | - | Common Stock | ||
| Day One Biopharmaceuticals... | Samuel Blackman | HEAD OF R&D | 15 Nov 2024 | 2,206 | 1,064,015 | - | 13.2 | 29,142 | Common Stock | |
| Day One Biopharmaceuticals... | Samuel Blackman | HEAD OF R&D | 15 Nov 2024 | 1,437 | 1,060,159 | - | - | Common Stock | ||
| Day One Biopharmaceuticals... | Samuel Blackman | HEAD OF R&D | 15 Nov 2024 | 1,437 | 11,504 | - | - | Restricted Stock Unit (RSU) | ||
| Day One Biopharmaceuticals... | Samuel Blackman | HEAD OF R&D | 15 Nov 2024 | 1,187 | 1,058,722 | - | - | Common Stock | ||
| Day One Biopharmaceuticals... | Samuel Blackman | HEAD OF R&D | 15 Nov 2024 | 1,187 | 4,756 | - | - | Restricted Stock Unit (RSU) | ||
| Day One Biopharmaceuticals... | Samuel Blackman | HEAD OF R&D | 08 Nov 2024 | 18,255 | 1,067,535 | - | 16.2 | 295,229 | Common Stock | |
| Day One Biopharmaceuticals... | Samuel Blackman | HEAD OF R&D | 08 Nov 2024 | 10,000 | 1,057,535 | - | 16.1 | 160,994 | Common Stock | |
| Day One Biopharmaceuticals... | Samuel Blackman | HEAD OF R&D | 07 Nov 2024 | 11,245 | 1,085,790 | - | 16.0 | 180,287 | Common Stock | |
| Day One Biopharmaceuticals... | Samuel Blackman | HEAD OF R&D | 31 Oct 2024 | 500 | 1,097,035 | - | 16.0 | 8,010 | Common Stock | |
| Day One Biopharmaceuticals... | Samuel Blackman | HEAD OF R&D | 10 Sep 2024 | 30,000 | 1,097,535 | - | 14.2 | 426,675 | Common Stock | |
| Day One Biopharmaceuticals... | Samuel Blackman | HEAD OF R&D | 15 Aug 2024 | 6,062 | 1,129,767 | - | - | Common Stock | ||
| Day One Biopharmaceuticals... | Samuel Blackman | HEAD OF R&D | 15 Aug 2024 | 6,062 | 78,814 | - | - | Restricted Stock Unit (RSU) | ||
| Day One Biopharmaceuticals... | Samuel Blackman | HEAD OF R&D | 15 Aug 2024 | 2,232 | 1,127,535 | - | 14.0 | 31,246 | Common Stock | |
| Day One Biopharmaceuticals... | Samuel Blackman | HEAD OF R&D | 15 Aug 2024 | 1,437 | 1,123,705 | - | - | Common Stock | ||
| Day One Biopharmaceuticals... | Samuel Blackman | HEAD OF R&D | 15 Aug 2024 | 1,437 | 12,941 | - | - | Restricted Stock Unit (RSU) | ||
| Day One Biopharmaceuticals... | Samuel Blackman | HEAD OF R&D | 15 Aug 2024 | 1,187 | 1,122,268 | - | - | Common Stock | ||
| Day One Biopharmaceuticals... | Samuel Blackman | HEAD OF R&D | 15 Aug 2024 | 1,187 | 5,943 | - | - | Restricted Stock Unit (RSU) | ||
| Day One Biopharmaceuticals... | Samuel Blackman | HEAD OF R&D | 16 Jul 2024 | 20,000 | 1,121,081 | - | 16.0 | 320,226 | Common Stock | |
| Day One Biopharmaceuticals... | Samuel Blackman | HEAD OF R&D | 10 Jun 2024 | 30,000 | 1,141,081 | - | 12.6 | 378,588 | Common Stock | |
| Day One Biopharmaceuticals... | Samuel Blackman | HEAD OF R&D | 15 May 2024 | 6,062 | 1,173,348 | - | - | Common Stock | ||
| Day One Biopharmaceuticals... | Samuel Blackman | HEAD OF R&D | 15 May 2024 | 6,062 | 84,876 | - | - | Restricted Stock Unit (RSU) | ||
| Day One Biopharmaceuticals... | Samuel Blackman | HEAD OF R&D | 15 May 2024 | 2,267 | 1,171,081 | - | 16.1 | 36,450 | Common Stock | |
| Day One Biopharmaceuticals... | Samuel Blackman | HEAD OF R&D | 15 May 2024 | 1,437 | 1,167,286 | - | - | Common Stock | ||
| Day One Biopharmaceuticals... | Samuel Blackman | HEAD OF R&D | 15 May 2024 | 1,437 | 14,378 | - | - | Restricted Stock Unit (RSU) | ||
| Day One Biopharmaceuticals... | Samuel Blackman | HEAD OF R&D | 15 May 2024 | 1,187 | 1,165,849 | - | - | Common Stock | ||
| Day One Biopharmaceuticals... | Samuel Blackman | HEAD OF R&D | 15 May 2024 | 1,187 | 7,130 | - | - | Restricted Stock Unit (RSU) | ||
| Day One Biopharmaceuticals... | Samuel Blackman | HEAD OF R&D | 10 May 2024 | 10,000 | 1,164,662 | - | 16.4 | 163,743 | Common Stock | |
| Day One Biopharmaceuticals... | Samuel Blackman | HEAD OF R&D | 18 Apr 2024 | 10,000 | 1,174,662 | - | 16.0 | 160,163 | Common Stock | |
| Day One Biopharmaceuticals... | Samuel Blackman | HEAD OF R&D | 25 Mar 2024 | 10,000 | 1,184,662 | - | 16.0 | 160,055 | Common Stock | |
| Day One Biopharmaceuticals... | Samuel Blackman | HEAD OF R&D | 11 Mar 2024 | 30,000 | 1,194,662 | - | 15.2 | 457,314 | Common Stock | |
| Day One Biopharmaceuticals... | Samuel Blackman | HEAD OF R&D | 27 Feb 2024 | 20,000 | 1,224,662 | - | 16.1 | 322,166 | Common Stock | |
| Day One Biopharmaceuticals... | Samuel Blackman | HEAD OF RESEARCH AND DEVELOPME | 15 Feb 2024 | 6,062 | 90,938 | - | - | Restricted Stock Unit (RSU) | ||
| Day One Biopharmaceuticals... | Blackman Samuel | HEAD OF RESEARCH AND DEVELOPME | 15 Feb 2024 | 6,062 | 1,246,920 | - | - | Common Stock | ||
| Day One Biopharmaceuticals... | Blackman Samuel | HEAD OF RESEARCH AND DEVELOPME | 15 Feb 2024 | 2,258 | 1,244,662 | - | 15.2 | 34,430 | Common Stock | |
| Day One Biopharmaceuticals... | Blackman Samuel | HEAD OF RESEARCH AND DEVELOPME | 15 Feb 2024 | 1,437 | 1,240,858 | - | - | Common Stock | ||
| Day One Biopharmaceuticals... | Blackman Samuel | HEAD OF RESEARCH AND DEVELOPME | 15 Feb 2024 | 1,437 | 15,815 | - | - | Restricted Stock Unit (RSU) | ||
| Day One Biopharmaceuticals... | Blackman Samuel | HEAD OF RESEARCH AND DEVELOPME | 15 Feb 2024 | 1,187 | 8,317 | - | - | Restricted Stock Unit (RSU) | ||
| Day One Biopharmaceuticals... | Samuel Blackman | HEAD OF RESEARCH AND DEVELOPME | 15 Feb 2024 | 1,187 | 1,239,421 | - | - | Common Stock | ||
| Day One Biopharmaceuticals... | Blackman Samuel | Head of Research and Developme | 05 Jan 2024 | 148,000 | 148,000 | - | - | Stock Option (right to buy Common Stock) | ||
| Day One Biopharmaceuticals... | Blackman Samuel | Head of Research and Developme | 05 Jan 2024 | 97,000 | 97,000 | - | - | Restricted Stock Units | ||
| Day One Biopharmaceuticals... | Samuel Blackman | Head of Research and Developme | 15 Aug 2023 | 1,437 | 18,689 | - | - | Restricted Stock Units | ||
| Day One Biopharmaceuticals... | Samuel Blackman | Head of Research and Developme | 15 Aug 2023 | 1,437 | 1,236,987 | - | - | Common Stock | ||
| Day One Biopharmaceuticals... | Samuel Blackman | Head of Research and Developme | 15 Aug 2023 | 1,187 | 10,691 | - | - | Restricted Stock Units | ||
| Day One Biopharmaceuticals... | Samuel Blackman | Head of Research and Developme | 15 Aug 2023 | 1,187 | 1,235,550 | - | - | Common Stock | ||
| Day One Biopharmaceuticals... | Samuel Blackman | Head of Research and Developme | 15 Aug 2023 | 668 | 1,236,319 | - | 13.9 | 9,258 | Common Stock | |
| Day One Biopharmaceuticals... | Samuel Blackman | Chief Medical Officer | 05 Jun 2023 | 1,229 | 1,234,363 | - | 16 | 19,664 | Common Stock | |
| Day One Biopharmaceuticals... | Samuel Blackman | Chief Medical Officer | 15 May 2023 | 1,437 | 1,236,284 | - | - | Common Stock | ||
| Day One Biopharmaceuticals... | Samuel Blackman | Chief Medical Officer | 15 May 2023 | 1,437 | 20,126 | - | - | Restricted Stock Units | ||
| Day One Biopharmaceuticals... | Samuel Blackman | Chief Medical Officer | 15 May 2023 | 1,187 | 1,234,847 | - | - | Common Stock | ||
| Day One Biopharmaceuticals... | Samuel Blackman | Chief Medical Officer | 15 May 2023 | 1,187 | 11,878 | - | - | Restricted Stock Units | ||
| Day One Biopharmaceuticals... | Samuel Blackman | Chief Medical Officer | 15 May 2023 | 692 | 1,235,592 | - | 13.1 | 9,081 | Common Stock | |
| Day One Biopharmaceuticals... | Samuel Blackman | Chief Medical Officer | 10 Mar 2023 | 10,000 | 1,233,660 | - | 18.0 | 180,484 | Common Stock | |
| Day One Biopharmaceuticals... | Samuel Blackman | Chief Medical Officer | 15 Feb 2023 | 1,437 | 21,563 | - | - | Restricted Stock Units | ||
| Day One Biopharmaceuticals... | Samuel Blackman | Chief Medical Officer | 15 Feb 2023 | 1,437 | 1,244,334 | - | - | Common Stock | ||
| Day One Biopharmaceuticals... | Samuel Blackman | Chief Medical Officer | 15 Feb 2023 | 1,187 | 13,065 | - | - | Restricted Stock Units | ||
| Day One Biopharmaceuticals... | Samuel Blackman | Chief Medical Officer | 15 Feb 2023 | 1,187 | 1,242,897 | - | - | Common Stock | ||
| Day One Biopharmaceuticals... | Samuel Blackman | Chief Medical Officer | 15 Feb 2023 | 674 | 1,243,660 | - | 19.6 | 13,192 | Common Stock | |
| Day One Biopharmaceuticals... | Samuel Blackman | Chief Medical Officer | 10 Feb 2023 | 10,000 | 1,241,710 | - | 20.1 | 200,659 | Common Stock | |
| Day One Biopharmaceuticals... | Samuel Blackman | Chief Medical Officer | 17 Jan 2023 | 72,000 | 72,000 | - | - | Stock Option (right to buy Common Stock) | ||
| Day One Biopharmaceuticals... | Samuel Blackman | Chief Medical Officer | 17 Jan 2023 | 23,000 | 23,000 | - | - | Restricted Stock Units | ||
| Day One Biopharmaceuticals... | Samuel Blackman | Chief Medical Officer | 10 Jan 2023 | 7,500 | 1,252,648 | - | 22.8 | 170,633 | Common Stock | |
| Day One Biopharmaceuticals... | Samuel Blackman | Chief Medical Officer | 10 Jan 2023 | 2,500 | 1,250,148 | - | 23.2 | 58,011 | Common Stock | |
| Day One Biopharmaceuticals... | Samuel Blackman | Chief Medical Officer | 01 Dec 2022 | 9,100 | 1,261,048 | - | 21.4 | 194,590 | Common Stock | |
| Day One Biopharmaceuticals... | Samuel Blackman | Chief Medical Officer | 01 Dec 2022 | 900 | 1,260,148 | - | 22.2 | 19,940 | Common Stock | |
| Day One Biopharmaceuticals... | Samuel Blackman | Chief Medical Officer | 15 Nov 2022 | 1,187 | 1,270,525 | - | - | Common Stock | ||
| Day One Biopharmaceuticals... | Samuel Blackman | Chief Medical Officer | 15 Nov 2022 | 1,187 | 14,252 | - | - | Restricted Stock Units | ||
| Day One Biopharmaceuticals... | Samuel Blackman | Chief Medical Officer | 15 Nov 2022 | 377 | 1,270,148 | - | 21.5 | 8,090 | Common Stock | |
| Day One Biopharmaceuticals... | Samuel Blackman | Chief Medical Officer | 01 Nov 2022 | 10,000 | 1,269,338 | - | 20.0 | 200,050 | Common Stock | |
| Day One Biopharmaceuticals... | Samuel Blackman | Chief Medical Officer | 03 Oct 2022 | 10,000 | 1,279,338 | - | 20.0 | 199,852 | Common Stock | |
| Day One Biopharmaceuticals... | Samuel Blackman | Chief Medical Officer | 01 Sep 2022 | 8,411 | 1,290,927 | - | 23.1 | 194,643 | Common Stock | |
| Day One Biopharmaceuticals... | Samuel Blackman | Chief Medical Officer | 01 Sep 2022 | 1,589 | 1,289,338 | - | 23.8 | 37,808 | Common Stock | |
| Day One Biopharmaceuticals... | Samuel Blackman | Chief Medical Officer | 15 Aug 2022 | 3,561 | 1,300,279 | - | 0 | Common Stock | ||
| Day One Biopharmaceuticals... | Samuel Blackman | Chief Medical Officer | 15 Aug 2022 | 3,561 | 15,439 | - | - | Restricted Stock Units | ||
| Day One Biopharmaceuticals... | Samuel Blackman | Chief Medical Officer | 15 Aug 2022 | 941 | 1,299,338 | - | 24.3 | 22,876 | Common Stock | |
| Day One Biopharmaceuticals... | Samuel Blackman | Chief Medical Officer | 01 Aug 2022 | 10,000 | 1,296,718 | - | 16.9 | 168,810 | Common Stock | |
| Day One Biopharmaceuticals... | Samuel Blackman | Chief Medical Officer | 01 Jul 2022 | 5,824 | 1,310,894 | - | 18.2 | 106,237 | Common Stock | |
| Day One Biopharmaceuticals... | Samuel Blackman | Chief Medical Officer | 01 Jul 2022 | 3,309 | 1,307,585 | - | 19.2 | 63,625 | Common Stock | |
| Day One Biopharmaceuticals... | Samuel Blackman | Chief Medical Officer | 01 Jul 2022 | 867 | 1,306,718 | - | 19.9 | 17,296 | Common Stock | |
| Day One Biopharmaceuticals... | Samuel Blackman | Chief Medical Officer | 18 Jan 2022 | 135,000 | 135,000 | - | - | Stock Option (right to buy Common Stock) | ||
| Day One Biopharmaceuticals... | Samuel Blackman | Chief Medical Officer | 18 Jan 2022 | 19,000 | 19,000 | - | - | Restricted Stock Units | ||
| Day One Biopharmaceuticals... | Samuel Blackman | Chief Medical Officer | 03 Jan 2022 | 6,672 | 1,370,046 | - | 16.9 | 113,074 | Common Stock | |
| Day One Biopharmaceuticals... | Samuel Blackman | Chief Medical Officer | 03 Jan 2022 | 3,328 | 1,366,718 | - | 17.4 | 57,944 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges